204 related articles for article (PubMed ID: 34894384)
1. Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis.
Yamana K; Inoue J; Yoshida R; Sakata J; Nakashima H; Arita H; Kawaguchi S; Gohara S; Nagao Y; Takeshita H; Maeshiro M; Liu R; Matsuoka Y; Hirayama M; Kawahara K; Nagata M; Hirosue A; Toya R; Murakami R; Kuwahara Y; Fukumoto M; Nakayama H
J Extracell Vesicles; 2021 Dec; 10(14):e12169. PubMed ID: 34894384
[TBL] [Abstract][Full Text] [Related]
2. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma
Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS; Kwon TG; Kim JW; Lee ST; Choi SY; Hong SH
Theranostics; 2024; 14(2):460-479. PubMed ID: 38169528
[No Abstract] [Full Text] [Related]
4. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma.
Shiiba M; Shinozuka K; Saito K; Fushimi K; Kasamatsu A; Ogawara K; Uzawa K; Ito H; Takiguchi Y; Tanzawa H
Br J Cancer; 2013 May; 108(9):1817-21. PubMed ID: 23591197
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
[TBL] [Abstract][Full Text] [Related]
6. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
7. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
9. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs that target amyloid precursor protein processing machinery in extracellular vesicles and particles derived from oral squamous cells carcinoma.
Galvão F; Rode MP; de Campos PS; Bruch GE; Carregal VM; Massensini AR; Matte BF; Lamers ML; Creczynski-Pasa TB; Siqueira IR
J Oral Pathol Med; 2023 Oct; 52(9):877-884. PubMed ID: 37549991
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
Palve VC; Teni TR
Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
[TBL] [Abstract][Full Text] [Related]
12. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
13. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression.
Yang Z; Chen W; Wang Y; Qin M; Ji Y
Cell Biol Int; 2021 Jul; 45(7):1423-1435. PubMed ID: 33675276
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
15. miR-29a-3p enhances the radiosensitivity of oral squamous cell carcinoma cells by inhibiting ADAM12.
Jiang C; Liu F; Xiao S; He L; Wu W; Zhao Q
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34587717
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
Zhu X; Zhang H; Xu J
Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
[TBL] [Abstract][Full Text] [Related]
17. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
[TBL] [Abstract][Full Text] [Related]
18. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
[TBL] [Abstract][Full Text] [Related]
20. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]